부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Company news | Contera Pharma, subsidiary of Bukwang, raised 51 billion KRW..
Contera Pharma (“Contera”), subsidiary of Bukwang Pharmaceutical (“Bukwang”), an..
2020.06.30
Product news | Bukwang exports hipnotic-sedative emergency drug for COVID-..
Midazolam export to Luxembourg and France completed, the United Kingdom and Chil..
2020.06.08
R&D news | Bukwang’s antiviral drug, Levovir®, confirms antiviral effec..
Levovir demonstrated comparable efficacy to KALETRA® against coronavirus in vitr..
2020.03.10
Product news | Bukwang Initiates Exportation of its In-House-Developed Drug..
- Kalbe International to take on sales in 2 approved countriesBukwang Pharmaceut..
2020.01.31
Company news | ProteKt Therapeutics Raises $3.6 Million in Post-incubation..
ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor base..
2019.11.13
Company news | ASLAN PHARMACEUTICALS AND BUKWANG PHARMACEUTICAL ESTABLISH ..
-ASLAN spins out pre-clinical assets in joint venture with Bukwang to form JAGUA..
2019.09.30
1
2
3
4
5